Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
lipid nanoparticle drug delivery tech
Biotech
AbbVie inks $2.1B Capstan buyout to enter in vivo CAR-T market
AbbVie is making a full strength play for the in vivo CAR-T market, snapping up Capstan to add an early-phase autoimmune candidate to its pipeline.
Nick Paul Taylor
Jun 30, 2025 9:45am
NewLimit raises $130M to push liver mRNA med into clinic
May 6, 2025 11:00am
Tune Tx's $175M series B to fund epigenetic HBV therapy's trials
Jan 13, 2025 8:23am
Etherna lands $950M biobucks deal with Kenneth Chien's Dropshot
Jan 9, 2025 1:05pm
Vertex and Orna team up to develop new blood disorder treatments
Jan 7, 2025 7:00am
Oncology biotech licenses Genevant tech for up to $123M
Dec 20, 2024 6:00am
